Substituted quinazoline compounds useful as p38 kinase...

Details Substituted quinazoline compounds useful as p38 kinase... Substituted quinazoline compounds useful as p38 kinase...

2007-03-27

2008-11-25

Shameem, Golam M (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S224000, C544S242000, C544S253000, C544S292000, C514S247000, C514S256000, C514S257000

Reexamination Certificate

active

07456185

ABSTRACT:
Compounds having the formula (I),are useful as p38 kinase inhibitors, wherein R4and R5are hydrogen, halogen, cyano, haloalkyl, or haloalkoxy, but are not both hydrogen; R6and R7are optional substituents, and Q is a non-aromatic moiety as defined in the specification.

REFERENCES:
patent: 3594480 (1971-07-01), Cronin et al.
patent: 4672116 (1987-06-01), Bandurco et al.
patent: 5084463 (1992-01-01), Butera et al.
patent: 5444062 (1995-08-01), Coe et al.
patent: 6313294 (2001-11-01), Chou et al.
patent: 6476031 (2002-11-01), Chakravarty et al.
patent: 7238698 (2007-07-01), Dunn et al.
patent: 2002/0061879 (2002-05-01), Garvey et al.
patent: 1 052 254 (2000-11-01), None
patent: 1 110 552 (2001-06-01), None
patent: 1024908 (1966-04-01), None
patent: WO 92/01675 (1992-02-01), None
patent: WO 92/07844 (1992-05-01), None
patent: WO 98/38984 (1998-09-01), None
patent: WO 01/32632 (2001-05-01), None
patent: WO 01/38315 (2001-05-01), None
patent: WO 01/64646 (2001-09-01), None
patent: WO 02/08224 (2002-01-01), None
patent: WO 02/50045 (2002-06-01), None
patent: WO 02/085908 (2002-10-01), None
Shewchuk, L., et al, “Binding Mode of the 4-Anilinoquinazoline Class of Protein Kinase Inhibitor: X-ray Crystallographic Studies of 4-Anilinoquinazolines Bound to Cyclin-Dependent Kinase 2 and p38 Kinase”, J. Med. Chem, 2000, 43:133-138 (XP002293111, compounds 1-3).
Wandel, et al, “P-Glycoprotein and Cytochrome P-450 3A Inhibition: Dissociation of Inhibitory Potencies1”, Cancer Research, Aug. 15, 1999, pp. 3944-3948, vol. 59:16.
Webb, et al., “Quinazolines as Adenosine Receptor Antagonists: SAR and Selectivity for A2BReceptors”, Bioorganic & Medicinal Chemistry, (2003), pp. 77-85, vol. 11.
Hess, et al., “Antihypertensive 2-Amino-4(3H)-quinazolines”, Journal of Medicinal Chemistry, (1968), pp. 130-136, vol. 11:1.

Affiliated with

Also associated with

Rating

Substituted quinazoline compounds useful as p38 kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted quinazoline compounds useful as p38 kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinazoline compounds useful as p38 kinase... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4048634